Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non‐transfusion‐dependent β‐thalassaemia
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2021-07, Vol.194 (2), p.474-477 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 477 |
|---|---|
| container_issue | 2 |
| container_start_page | 474 |
| container_title | British journal of haematology |
| container_volume | 194 |
| creator | Taher, Ali T. Viprakasit, Vip Cappellini, Maria Domenica Kraus, Dominik Cech, Patrick Volz, Dietmar Winter, Erica Nave, Stephane Dukart, Juergen Khwaja, Omar Koerner, Annette Hermosilla, Ricardo Brugnara, Carlo |
| description | |
| doi_str_mv | 10.1111/bjh.17479 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2520854553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2551545060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3889-ee244c6543172b5239d2ad8d4633be7ef99a112a5056e93f74ad4790c01164f13</originalsourceid><addsrcrecordid>eNp10U1u1DAUB3CrKqLTwqIXQJa6oVLT-sV2PpZtBQyoEhtYR07y3PEosYPtqJodR-AAnIKDcAhOgmem7QIJb-xn__yX5UfIKbBLSOOqXa8uoRRlfUAWwAuZ5SDgkCwYY2UGTFRH5DiENWPAmYSX5IjzmkMlywX5uVQ4qugGd286NVDUGrsYqNPU-VSrfjTWhOhVNM5ut1sT3YQ-GntBFb0fNp2xSBOwYXI-UmNXZmv8RVrSKd1DmwIfTFxR6-yf7z92Vs_B7KoeJ7R9MvT3r-3hSg0qhPQqo16RF1oNAV8_zifk6_t3X26X2d3nDx9vr--yjldVnSHmQnSFFBzKvJU5r_tc9VUvCs5bLFHXtQLIlWSywJrrUqg-fRbrGEAhNPAT8nafO3n3bcYQm9GEDodBWXRzaHKZs0oKKXmiZ__QtZu9Ta9LSkJCrGBJne9V510IHnUzeTMqv2mANduWNallza5lyb55TJzbEftn-dSjBK724MEMuPl_UnPzabmP_Asg2aYv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2551545060</pqid></control><display><type>article</type><title>Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non‐transfusion‐dependent β‐thalassaemia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><creator>Taher, Ali T. ; Viprakasit, Vip ; Cappellini, Maria Domenica ; Kraus, Dominik ; Cech, Patrick ; Volz, Dietmar ; Winter, Erica ; Nave, Stephane ; Dukart, Juergen ; Khwaja, Omar ; Koerner, Annette ; Hermosilla, Ricardo ; Brugnara, Carlo</creator><creatorcontrib>Taher, Ali T. ; Viprakasit, Vip ; Cappellini, Maria Domenica ; Kraus, Dominik ; Cech, Patrick ; Volz, Dietmar ; Winter, Erica ; Nave, Stephane ; Dukart, Juergen ; Khwaja, Omar ; Koerner, Annette ; Hermosilla, Ricardo ; Brugnara, Carlo</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.17479</identifier><identifier>PMID: 33931857</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Administration, Oral ; Adult ; beta-Thalassemia - blood ; beta-Thalassemia - drug therapy ; bitopertin ; Erythrocyte Count ; Female ; Glycine Plasma Membrane Transport Proteins - antagonists & inhibitors ; haem ; Hemoglobins - analysis ; Humans ; iron ; Male ; Oral administration ; Piperazines - administration & dosage ; Piperazines - therapeutic use ; reactive oxygen species ; Sulfones - administration & dosage ; Sulfones - therapeutic use ; Thalassemia ; Young Adult ; β‐thalassemia</subject><ispartof>British journal of haematology, 2021-07, Vol.194 (2), p.474-477</ispartof><rights>2021 British Society for Haematology and John Wiley & Sons Ltd</rights><rights>Copyright © 2021 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3889-ee244c6543172b5239d2ad8d4633be7ef99a112a5056e93f74ad4790c01164f13</citedby><cites>FETCH-LOGICAL-c3889-ee244c6543172b5239d2ad8d4633be7ef99a112a5056e93f74ad4790c01164f13</cites><orcidid>0000-0001-8676-6864 ; 0000-0001-8515-2238 ; 0000-0001-8192-8713</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.17479$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.17479$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,1432,27923,27924,45573,45574,46408,46832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33931857$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taher, Ali T.</creatorcontrib><creatorcontrib>Viprakasit, Vip</creatorcontrib><creatorcontrib>Cappellini, Maria Domenica</creatorcontrib><creatorcontrib>Kraus, Dominik</creatorcontrib><creatorcontrib>Cech, Patrick</creatorcontrib><creatorcontrib>Volz, Dietmar</creatorcontrib><creatorcontrib>Winter, Erica</creatorcontrib><creatorcontrib>Nave, Stephane</creatorcontrib><creatorcontrib>Dukart, Juergen</creatorcontrib><creatorcontrib>Khwaja, Omar</creatorcontrib><creatorcontrib>Koerner, Annette</creatorcontrib><creatorcontrib>Hermosilla, Ricardo</creatorcontrib><creatorcontrib>Brugnara, Carlo</creatorcontrib><title>Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non‐transfusion‐dependent β‐thalassaemia</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Administration, Oral</subject><subject>Adult</subject><subject>beta-Thalassemia - blood</subject><subject>beta-Thalassemia - drug therapy</subject><subject>bitopertin</subject><subject>Erythrocyte Count</subject><subject>Female</subject><subject>Glycine Plasma Membrane Transport Proteins - antagonists & inhibitors</subject><subject>haem</subject><subject>Hemoglobins - analysis</subject><subject>Humans</subject><subject>iron</subject><subject>Male</subject><subject>Oral administration</subject><subject>Piperazines - administration & dosage</subject><subject>Piperazines - therapeutic use</subject><subject>reactive oxygen species</subject><subject>Sulfones - administration & dosage</subject><subject>Sulfones - therapeutic use</subject><subject>Thalassemia</subject><subject>Young Adult</subject><subject>β‐thalassemia</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10U1u1DAUB3CrKqLTwqIXQJa6oVLT-sV2PpZtBQyoEhtYR07y3PEosYPtqJodR-AAnIKDcAhOgmem7QIJb-xn__yX5UfIKbBLSOOqXa8uoRRlfUAWwAuZ5SDgkCwYY2UGTFRH5DiENWPAmYSX5IjzmkMlywX5uVQ4qugGd286NVDUGrsYqNPU-VSrfjTWhOhVNM5ut1sT3YQ-GntBFb0fNp2xSBOwYXI-UmNXZmv8RVrSKd1DmwIfTFxR6-yf7z92Vs_B7KoeJ7R9MvT3r-3hSg0qhPQqo16RF1oNAV8_zifk6_t3X26X2d3nDx9vr--yjldVnSHmQnSFFBzKvJU5r_tc9VUvCs5bLFHXtQLIlWSywJrrUqg-fRbrGEAhNPAT8nafO3n3bcYQm9GEDodBWXRzaHKZs0oKKXmiZ__QtZu9Ta9LSkJCrGBJne9V510IHnUzeTMqv2mANduWNallza5lyb55TJzbEftn-dSjBK724MEMuPl_UnPzabmP_Asg2aYv</recordid><startdate>202107</startdate><enddate>202107</enddate><creator>Taher, Ali T.</creator><creator>Viprakasit, Vip</creator><creator>Cappellini, Maria Domenica</creator><creator>Kraus, Dominik</creator><creator>Cech, Patrick</creator><creator>Volz, Dietmar</creator><creator>Winter, Erica</creator><creator>Nave, Stephane</creator><creator>Dukart, Juergen</creator><creator>Khwaja, Omar</creator><creator>Koerner, Annette</creator><creator>Hermosilla, Ricardo</creator><creator>Brugnara, Carlo</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8676-6864</orcidid><orcidid>https://orcid.org/0000-0001-8515-2238</orcidid><orcidid>https://orcid.org/0000-0001-8192-8713</orcidid></search><sort><creationdate>202107</creationdate><title>Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non‐transfusion‐dependent β‐thalassaemia</title><author>Taher, Ali T. ; Viprakasit, Vip ; Cappellini, Maria Domenica ; Kraus, Dominik ; Cech, Patrick ; Volz, Dietmar ; Winter, Erica ; Nave, Stephane ; Dukart, Juergen ; Khwaja, Omar ; Koerner, Annette ; Hermosilla, Ricardo ; Brugnara, Carlo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3889-ee244c6543172b5239d2ad8d4633be7ef99a112a5056e93f74ad4790c01164f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>beta-Thalassemia - blood</topic><topic>beta-Thalassemia - drug therapy</topic><topic>bitopertin</topic><topic>Erythrocyte Count</topic><topic>Female</topic><topic>Glycine Plasma Membrane Transport Proteins - antagonists & inhibitors</topic><topic>haem</topic><topic>Hemoglobins - analysis</topic><topic>Humans</topic><topic>iron</topic><topic>Male</topic><topic>Oral administration</topic><topic>Piperazines - administration & dosage</topic><topic>Piperazines - therapeutic use</topic><topic>reactive oxygen species</topic><topic>Sulfones - administration & dosage</topic><topic>Sulfones - therapeutic use</topic><topic>Thalassemia</topic><topic>Young Adult</topic><topic>β‐thalassemia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taher, Ali T.</creatorcontrib><creatorcontrib>Viprakasit, Vip</creatorcontrib><creatorcontrib>Cappellini, Maria Domenica</creatorcontrib><creatorcontrib>Kraus, Dominik</creatorcontrib><creatorcontrib>Cech, Patrick</creatorcontrib><creatorcontrib>Volz, Dietmar</creatorcontrib><creatorcontrib>Winter, Erica</creatorcontrib><creatorcontrib>Nave, Stephane</creatorcontrib><creatorcontrib>Dukart, Juergen</creatorcontrib><creatorcontrib>Khwaja, Omar</creatorcontrib><creatorcontrib>Koerner, Annette</creatorcontrib><creatorcontrib>Hermosilla, Ricardo</creatorcontrib><creatorcontrib>Brugnara, Carlo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taher, Ali T.</au><au>Viprakasit, Vip</au><au>Cappellini, Maria Domenica</au><au>Kraus, Dominik</au><au>Cech, Patrick</au><au>Volz, Dietmar</au><au>Winter, Erica</au><au>Nave, Stephane</au><au>Dukart, Juergen</au><au>Khwaja, Omar</au><au>Koerner, Annette</au><au>Hermosilla, Ricardo</au><au>Brugnara, Carlo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non‐transfusion‐dependent β‐thalassaemia</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2021-07</date><risdate>2021</risdate><volume>194</volume><issue>2</issue><spage>474</spage><epage>477</epage><pages>474-477</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>33931857</pmid><doi>10.1111/bjh.17479</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-8676-6864</orcidid><orcidid>https://orcid.org/0000-0001-8515-2238</orcidid><orcidid>https://orcid.org/0000-0001-8192-8713</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2021-07, Vol.194 (2), p.474-477 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2520854553 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Free Content |
| subjects | Administration, Oral Adult beta-Thalassemia - blood beta-Thalassemia - drug therapy bitopertin Erythrocyte Count Female Glycine Plasma Membrane Transport Proteins - antagonists & inhibitors haem Hemoglobins - analysis Humans iron Male Oral administration Piperazines - administration & dosage Piperazines - therapeutic use reactive oxygen species Sulfones - administration & dosage Sulfones - therapeutic use Thalassemia Young Adult β‐thalassemia |
| title | Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non‐transfusion‐dependent β‐thalassaemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A51%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haematological%20effects%20of%20oral%20administration%20of%20bitopertin,%20a%20glycine%20transport%20inhibitor,%20in%20patients%20with%20non%E2%80%90transfusion%E2%80%90dependent%20%CE%B2%E2%80%90thalassaemia&rft.jtitle=British%20journal%20of%20haematology&rft.au=Taher,%20Ali%20T.&rft.date=2021-07&rft.volume=194&rft.issue=2&rft.spage=474&rft.epage=477&rft.pages=474-477&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.17479&rft_dat=%3Cproquest_cross%3E2551545060%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2551545060&rft_id=info:pmid/33931857&rfr_iscdi=true |